Refine by
Dna Technology Articles & Analysis
66 articles found
Fluorescent biopolymers are a critical link between biological science and advanced technology, finding essential applications in bioimaging, targeted drug delivery, and medical diagnostics. ...
ByMatexcel
The production of VLPs can be achieved through various methods, including recombinant DNA technology. This approach allows for the insertion of genes encoding viral proteins into suitable expression systems such as bacteria, yeast, or mammalian cells. ...
By utilizing advanced techniques such as recombinant DNA technology and high-throughput screening, service providers can efficiently create stable cell lines that produce high yields of antibodies. Infrastructure and Technology Modern CHO cell production facilities are equipped with cutting-edge technology, ensuring high-quality ...
These large-molecule compounds, often produced through recombinant DNA technology or advanced peptide synthesis, include monoclonal antibodies, therapeutic proteins, vaccines, and engineered peptides. ...
Through the synergy of recombinant DNA technology and high-throughput screening researchers develop therapies specifically designed to match the distinctive traits of tumors expressing FAP. ...
However, with advancements in biotechnology and biochemistry, the design of antibody-based therapies has undergone a paradigm shift. Techniques such as recombinant DNA technology and hybridoma technology have allowed scientists to create monoclonal antibodies, which are identical copies of a specific antibody that targets a particular antigen. ...
Alfa Cytology uses advanced biotechnological platforms which help them make the ADCs development process more efficient. Researchers use hybridoma technology along with recombinant DNA methods to create conjugates that match tumor biology in a precise manner. ...
This innovative approach has revolutionized the way vaccines are developed, manufactured, and administered, offering a promising alternative to traditional methods. By utilizing recombinant DNA technology, scientists can produce vaccines that are more effective and safer for public use. ...
The fields of gene editing and nanotechnology are on the cusp of unprecedented breakthroughs that could have transformative impacts on medicine, materials science, sustainable manufacturing, and more. Both gene editing and nanotechnology demand highly controlled environments for research, development, and production, and clean cold rooms will be key to maintaining the integrity of these ...
For large-scale applications, recombinant DNA technology has been employed to produce highly pure lysozyme for research and commercial purposes. ...
Furthermore, the advancement of recombinant DNA technology allows scientists to engineer proteins with desired conjugates. ...
Recombinant protein drugs are protein-based therapeutic drugs which are produced by using DNA recombination technology or other biotechnological methods. These drugs include cytokines, peptide hormones, recombinant enzymes, monoclonal antibodies, and fusion proteins. ...
Recombinant protein drugs are therapeutic protein drugs produced using DNA recombination technology or other biotechnologies. Compared to traditional low molecular synthetic drugs, they have the advantages of strong specificity, low toxicity, and significant therapeutic effects. ...
With the development of bioengineering technology, recombinant human collagen (rhCollagen) produced by recombinant DNA technology has been widely applied in various fields such as medicine, cosmetics, and tissue engineering. ...
By using antibodies customized for specific histone modifications, this method can selectively immunoprecipitate DNA fragments of histone modifications. Subsequently, these DNA fragments are fragmented and sequenced to reveal the precise location and relative abundance of histone modifications across the entire genome. ...
The antibody will bind to a specific location on the DNA sequence, and then a technology called fluorescence labeling is used to label the antibody. ...
Residual DNA comprises fragments or traces of DNA that linger following the creation of pharmaceuticals, especially those processed through recombinant technologies or from cell lines. ...
At the same time, these companies are constantly looking for new technologies for new drug development, such as high-throughput screening technology, DNA encoded chemical library, computer-aided drug discovery, and artificial intelligence. ...
Recombinant protein is a protein obtained by applying recombinant DNA/RNA technology. The production of recombinant proteins in vitro mainly includes four major systems: prokaryotic protein expression, mammalian cell protein expression, yeast protein expression and insect cell protein expression. ...
The evolution of genetic engineering and recombinant DNA technology has dramatically revolutionized the process of industrial enzyme production. ...